Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
Nonetheless, even at heavily discounted prices, products such as Wegovy and Zepbound still remain unaffordable for many
Some researchers adjust timing or escalation speed based on body weight
GLP-1 RAs promote satiety, reduce hunger, and dampen reward responsivity, which conceptually could open a temporary low-drive window during which behavioral techniques such as stimulus control, self-monitoring, and structured eating routines become more achievable
Fatigue should be differentiated from hypoglycemia, which can present with similar symptoms including weakness, shakiness, and difficulty concentrating
Tirzepatide treatment was not associated with excess cardiovascular risk (54, 74)